Getein CysC Fast Test Kit is used as an aid in the assessment and evaluation of index of glomerular filtration rate, and has important application value in renal function, kidney damage and renal transplantation.
CysC Fast Test Kit
(Immunofluorescence Assay)
CysC Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of Cystatin C (CysC) in serum, plasma or whole blood. The test result is used as an aid in the assessment and evaluation of index of glomerular filtration rate, and has important application value in renal function, kidney damage and renal transplantation.
About CysC
Cystatin C (CysC) is mainly used as a biomarker of kidney function. Cystatin C has a low molecular weight (approximately 13.3 kilodaltons), and it is removed from the bloodstream by glomerular filtration in the kidneys. If kidney function and glomerular filtration rate decline, the blood levels of cystatin C rise. Serum levels of cystatin C are a more precise test of kidney function (as represented by the glomerular filtration rate, GFR) than serum creatinine levels.
Contents
1. For Getein1100
Package specifications: 25 tests/box, 10 tests/box
1) CysC test card in a sealed pouch with desiccant
2) Capillary pipet
3) Sample diluent
4) User manual: 1 piece/box
5) SD/RFID card: 1 piece/box
2. For Getein1600
Package specifications: 2×24 tests/kit, 2×48 tests/kit
1) Sealed cartridge with 24/48 Getein CysC test cards
2) User manual: 1 piece/box
Materials required for Getein1600:
1) Sample diluent: 1 bottle/box
2) Box with pipette tips: 1 piece/box
3) Mixing plate: 1 piece/box
Note: Do not mix or interchange different batches of kits.
Specifications
Test Item |
Sample |
Method |
Storage Condition |
CysC |
S/P/WB |
Immunofluorescence Assay |
4-30℃ |
Detection Range |
Test Time |
Cut-off Value |
Shelf Life |
0.5~10.0 mg/L |
3 min |
0.51~1.09 mg/L |
24 months |
Applicable Device
Getein1100 Immunofluorescence Quantitative Analyzer
Getein1600 Immunofluorescence Quantitative Analyzer
Clinical Application
1. Early diagnosis of kidney disease.
2. Renal function monitoring of renal transplant patients and chemotherapy.
3. Prevention and early diagnosis of renal damage in high risk population of AKI.
4. Evaluation of renal function in liver cirrhosis.